By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Science Briefing
  • Medicine
  • Biology
  • Engineering
  • Environment
  • More
    • Dentistry
    • Chemistry
    • Physics
    • Agriculture
    • Business
    • Computer Science
    • Energy
    • Materials Science
    • Mathematics
    • Politics
    • Social Sciences
Notification
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Personalize
Science BriefingScience Briefing
Font ResizerAa
  • Home
  • My Feed
  • SubscribeNow
  • My Interests
  • My Saves
  • History
  • SurveysNew
Search
  • Quick Access
    • Home
    • Contact Us
    • Blog Index
    • History
    • My Saves
    • My Interests
    • My Feed
  • Categories
    • Business
    • Politics
    • Medicine
    • Biology

Top Stories

Explore the latest updated news!

This week’s Medicine Key Highlights

This week’s Medicine Key Highlights

A Causal Model for Predicting Severe Long COVID Complications

Stay Connected

Find us on socials
248.1KFollowersLike
61.1KFollowersFollow
165KSubscribersSubscribe
Made by ThemeRuby using the Foxiz theme. Powered by WordPress

Home - Hematology - Plasma’s dual messengers: Unlocking complementary diagnostics in inflammatory blood disorders

Hematology

Plasma’s dual messengers: Unlocking complementary diagnostics in inflammatory blood disorders

Last updated: March 21, 2026 5:00 am
By
Science Briefing
ByScience Briefing
Science Communicator
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Follow:
No Comments
Share
SHARE

Plasma’s dual messengers: Unlocking complementary diagnostics in inflammatory blood disorders

A recent study in Communications Medicine reveals a significant advancement in blood-based diagnostics for pediatric inflammatory syndromes. Researchers compared plasma cell-free RNA and protein profiles in children with Kawasaki disease and Multisystem Inflammatory Syndrome in Children (MIS-C). The key finding is that these two analytes—cell-free RNA and proteins—are largely uncorrelated, meaning they provide independent biological information. Despite this lack of correlation, each analyte alone demonstrated high accuracy in classifying the diseases. This research highlights the complementary diagnostic utility of multi-analyte liquid biopsies, moving beyond single-marker approaches to create a more robust molecular signature for complex hematological and inflammatory conditions.

Study Significance: For hematologists and clinicians, this work underscores the potential of integrating cell-free RNA analysis with traditional protein assays to improve diagnostic precision for inflammatory and hematologic disorders. The independent information from each analyte could lead to more accurate differential diagnoses, especially in complex cases like MIS-C which can present with hematological complications. This approach may eventually refine patient stratification and guide more targeted therapeutic decisions, enhancing personalized medicine strategies in hematology and immunology.

Source →

Stay curious. Stay informed — with Science Briefing.

Always double check the original article for accuracy.

- Advertisement -

Feedback

Share This Article
Facebook Flipboard Pinterest Whatsapp Whatsapp LinkedIn Tumblr Reddit Telegram Threads Bluesky Email Copy Link Print
Share
ByScience Briefing
Science Communicator
Follow:
Instant, tailored science briefings — personalized and easy to understand. Try 30 days free.
Previous Article This week’s Medicine Key Highlights
Next Article A Rare Vascular Complication of Takayasu Arteritis
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related Stories

Uncover the stories that related to the post!

Liver Fibrosis Biomarkers Forecast Survival in Complex Congenital Heart Disease

The Genetic Blueprint of Reproductive Failure: A Massive Cohort Study

Inflammation’s Hidden Pathway: A New Link to Brain Wiring and Disease

Weekly Journal Scan: VESALIUS-CV extends PCSK9 inhibition to the prevention of first major cardiovascular events

The Iron-Fueled Heart: How a New Form of Cell Death Drives Heart Failure

A New Frontier in Coagulation: Sivelestat’s Potential to Prevent Post-Surgical ARDS

A New Timeline for Cancer Screening: Colonoscopy Delays Show Minimal Risk

A Dual-Targeted Reset: CAR-T Therapy Reboots the Immune System in Lupus

Show More

Science Briefing delivers personalized, reliable summaries of new scientific papers—tailored to your field and interests—so you can stay informed without doing the heavy reading.

Science Briefing
  • Categories:
  • Medicine
  • Biology
  • Social Sciences
  • Gastroenterology
  • Surgery
  • Natural Language Processing
  • Engineering
  • Cell Biology
  • Genetics
  • Chemistry

Quick Links

  • My Feed
  • My Interests
  • History
  • My Saves

About US

  • Adverts
  • Our Jobs
  • Term of Use

ScienceBriefing.com, All rights reserved.

Personalize you Briefings
To Receive Instant, personalized science updates—only on the discoveries that matter to you.
Please enable JavaScript in your browser to complete this form.
Loading
Zero Spam, Cancel, Upgrade or downgrade anytime!
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?